NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.
November 8, 2025 — Research Highlights: Earlier blood transfusion after major surgery – when hemoglobin was below 10 g/dL rather than beow 7 g/dl - did not affect the risk of severe complications, such as death, heart attack, need for a heart procedure, kidney failure or stroke. However, the timing of the blood transfusion may be associated with a lower risk of irregular heartbeat and heart failure among people with heart disease, according to a new study of U.
November 8, 2025 — Research Highlights: Successful catheter ablation resulted in a low risk of stroke associated with atrial fibrillation (AFib), a type of irregular heart rhythm, according to an international study. Researchers said these findings may suggest that ongoing blood-thinning medication may not be needed after an ablation procedure.
November 8, 2025 — Research Highlights: Standard care, which included medication for those eligible, was better than a promising minimally invasive procedure for people with irregular heart rhythms who had high stroke and bleeding risk. The procedure seals off a small pouch of heart tissue, where most blood clots form in people with irregular heartbeat.
November 8, 2025 — Research Highlights: A one-month course of dual clot-preventing therapy followed by a single clot-prevention medication for the remainder of the standard 12-month regimen in adults with atrial fibrillation (AFib) who received a coronary stent was as effective as one year of continuous dual therapy for preventing stroke, heart attack and death. Participants treated with the one-month regimen experienced fewer bleeding problems than those in the year-long dual-treatment group.
November 8, 2025 — Research Highlights: For people who have experienced a heart attack or stroke, or who are at high risk of one and need further cholesterol lowering, a new daily pill may be a more convenient yet similarly effective option to injectable therapies. The oral medication, enlicitide, lowered LDL cholesterol by up to 60% and could eventually offer an option for people whose LDL levels remain above goal despite lifestyle changes and standard cholesterol medications like statins.
November 8, 2025 — Research Highlights: Results from the international VESALIUS-CV (TIMI 66) clinical trial found that among adults with atherosclerotic cardiovascular disease (ASCVD) or diabetes and no history of a prior heart attack or stroke, the PCSK9 inhibitor evolocumab reduced the risk of coronary heart disease death, heart attack, or ischemic stroke by 25%. Participants taking evolocumab also had a 19% reduction in the risk of coronary heart disease death, heart attack, ischemic stroke or arterial revascularization over a median of more than four and a half years follow-up.
November 8, 2025 — Research Highlights: In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and reduced triglycerides by about 55%. Cholesterol and triglyceride levels began to drop within the two weeks after treatment, with effects sustained for at least 60 days of follow-up.
November 8, 2025 — Research Highlights: In a small, short-term, Phase 2 clinical trial in adults, a first-of-its-kind medication reduced triglyceride levels in most patients by more than 60%. Called DR10624, the medication activates three different receptors linked to triglycerides: FGF21, glucagon and GLP-1 receptors.
November 7, 2025 — CALGARY, AB - November 7, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC: VYYRF) (the “Company” or “Voyageur”), a Canadian developer of pharmaceutical-grade barium and iodine for medical imaging contrast media, is pleased to announce, subject to regulatory approval, the appointment of Virginia Alling as an independent director.
November 7, 2025 — LOS ANGELES, CA - November 7, 2025 (NEWMEDIAWIRE) - Datavault AI (NASDAQ: DVLT), a leader in data monetization, credentialing and digital engagement, has partnered with Rodney’s Comedy Club to introduce a first-of-its-kind integration of its VerifyU, Joke Token, and ADIO(R) technologies - transforming live comedy into an interactive, data-driven experience. The collaboration makes Rodney’s the first U.
November 7, 2025 — LOS ANGELES, CA - November 7, 2025 (NEWMEDIAWIRE) - Forward Industries (NASDAQ: FORD), focused on building and managing the world's largest Solana treasury, recently made an initial treasury update announcement and revealed that the company’s total Solana (SOL) holdings have reached 6,871,599. 06 SOL (https://ibn.
November 7, 2025 — TOKYO - November 7, 2025 (NEWMEDIAWIRE) - Olympus Corporation (Olympus), a global MedTech leader dedicated to making people’s lives healthier, safer, and more fulfilling, today unveiled a comprehensive strategy to transform endoscopy-enabled care through innovation and operational excellence. The strategy aims to accelerate cutting-edge technologies and reinforce Olympus’ global leadership in MedTech, improving outcomes for millions of patients worldwide.
November 7, 2025 — by Meg Flippin Benzinga DETROIT, MICHIGAN - November 7, 2025 (NEWMEDIAWIRE) - IQSTEL Inc. (NASDAQ: IQST), a global connectivity, AI and digital company focused on diversifying its revenue stream, expects double-digit organic revenue growth in 2026, with 26% topline growth.
November 7, 2025 — By Meg Flippin Benzinga DETROIT, MICHIGAN - November 7, 2025 (NEWMEDIAWIRE) - Cycurion Inc. (NASDAQ: CYCU), an IT cybersecurity solutions and AI company protecting government agencies and corporations including Fortune 100 and 500 companies, is closing out 2025 on a high note with $73.
November 7, 2025 — By Meg Flippin, Benzinga Cboe and Benzinga will host a virtual webinar introducing the Cboe Magnificent 10 Index (MGTN) on November 13 at 11 am ET. The Magnificent 7 paradigm is getting an upgrade with the addition of Advanced Micro Devices Inc.
November 6, 2025 — ZUG, Switzerland - November 6, 2025 (NEWMEDIAWIRE) - LION E-Mobility AG (LION; ISIN: CH0560888270), a leading manufacturer of battery packs for electric mobility and energy storage solutions, announces that its subsidiary LION Smart Production GmbH has partnered with Castrol to facilitate the development of a new cutting-edge battery module for high-performance EV applications, combining LION Smart’s direct battery‑cooling innovation with Castrol’s advanced thermal fluids and battery thermal management expertise. The partnership aims to improve significantly battery thermal management for passenger cars, trucks and battery energy storage systems (BESS) worldwide, through direct battery cooling, a cutting‑edge approach that facilitates fast charging and discharging of battery cells that are submerged in a lightweight dielectric fluid.
November 6, 2025 — KOBLENZ, Germany - November 6, 2025 (NEWMEDIAWIRE) - The Supervisory Board of Stabilus SE (WKN: STAB1L, ISIN: DE000STAB1L8), one of the world's leading suppliers of motion control solutions for a wide range of industries, today resolved to propose Dr. Frank Heinricht for election to the Supervisory Board at the Annual General Meeting on February 4, 2026.
November 6, 2025 — By Johnny Rice, Benzinga DETROIT, MICHIGAN - November 6, 2025 (NEWMEDIAWIRE) - Imagine a material so critical that nearly every aspect of modern technology depends on it. That material is copper, and the critical metal is witnessing unprecedented demand.
